LINDORA S HUBEL
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CIRCLEVILLE, OH NPI 1609280205
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family OH Astellas Pharma US Inc All categories
General Payments — all program years on this page
$787.50
- Category: General Payments
- Program years: PY2021–2024
- Record count: 21
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $381.90 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $381.90 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $138.30 | 2 |
| Acerta Pharma LLC | $120.83 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $47.76 | 2 |
| Neurelis, Inc. | $44.12 | 1 |
| PFIZER INC. | $17.72 | 1 |
| Esperion Therapeutics, Inc. | $13.17 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086948743 | Novartis Pharmaceuticals Corporation | $28.46 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086948757 | Novartis Pharmaceuticals Corporation | $19.30 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104711367 | AstraZeneca Pharmaceuticals LP | $120.83 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1129468864 | Esperion Therapeutics, Inc. | $13.17 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131675687 | PFIZER INC. | $17.72 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139525620 | Astellas Pharma US Inc | $125.00 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139530360 | Astellas Pharma US Inc | $13.30 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145665250 | Neurelis, Inc. | $44.12 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.